SCHEMBL9611713

SCHEMBL9611713

Cc1ccc2c3ccccc3c3cccnc3c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.55
HSP90AA1 P07900 2/20 0.55
NPC1 O15118 1/20 0.55
CCR1 P32246 6/20 0.50
CCR8 P51685 5/20 0.50
CCR5 P51681 4/20 0.49
ALDH1A1 P00352 2/20 0.44
DHFR P00374 1/20 0.44
HTT P42858 2/20 0.42
PSMD14 O00487 1/20 0.42
COPS5 Q92905 1/20 0.42
SLC6A2 P23975 1/20 0.42
RAB9A P51151 1/20 0.41
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 2/20 0.40
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
MMP2 P08253 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21959272 0.94 L3MBTL1 (0.57) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL17612277 0.86 CCR1 (0.50) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL3786280 0.83 CCR1 (0.52) L3MBTL1CCR1CCR8CCR5ALDH1A1
SCHEMBL1254209 0.83 DHFR (0.56) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL15498016 0.83 L3MBTL1 (0.46) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL25205392 0.82 L3MBTL1 (0.57) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL31341382 0.82 L3MBTL1 (0.57) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL30608515 0.81 CCR1 (0.50) L3MBTL1CCR1CCR8CCR5ALDH1A1
SCHEMBL4993117 0.81 HSP90AA1 (0.64) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL13331070 0.79 L3MBTL1 (0.64) L3MBTL1HSP90AA1NPC1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11706972-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-07-18 US disclosed
US-20210028376-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-01-28 US disclosed
US-20170186969-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-29 US disclosed
US-20170186964-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-29 US disclosed
US-20170186978-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-29 US disclosed
US-20170117478-A1 ORGANIC LIGHT EMITTING DEVICE SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2017-04-27 US disclosed
US-20170069857-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2017-03-09 US disclosed
US-20170069857-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2017-03-09 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-9559311-B2 Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment IDEMITSU KOSAN CO., LTD. (JP) 2017-01-31 US disclosed
US-20160149139-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-05-26 US disclosed
US-9166175-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2015-10-20 US disclosed
US-9126943-B2 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
US-9126943-B2 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140239273-A1 ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT IDEMITSU KOSAN CO., LTD. (JP) 2014-08-28 US disclosed
US-20140145151-A1 Organic Electroluminescent Device With Delayed Fluorescence UNIVERSAL DISPLAY CORPORATION (US) 2014-05-29 US disclosed
US-20140145149-A1 Organic Luminescent Compound With Delayed Fluorescence UNIVERSAL DISPLAY CORPORATION (US) 2014-05-29 US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11706972-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OSBP L3MBTL1 2045/4885HSP90AA1 4154/4885NPC1 384/4885
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME H1-2, L1CAM, H1-0 L3MBTL1 758/4885HSP90AA1 1829/4885NPC1 1609/4885
US-20140145149-A1 Organic Luminescent Compound With Delayed Fluorescence OCIAD1, OCIAD2, MLYCD L3MBTL1 303/4885HSP90AA1 4342/4885NPC1 576/4885
US-20170069857-A1 Organic Electroluminescent Materials and Devices OCIAD2, OCIAD1, OSBP L3MBTL1 2045/4885HSP90AA1 4154/4885NPC1 384/4885
US-20170117478-A1 ORGANIC LIGHT EMITTING DEVICE CRY2, ELOVL1, LAGE3 L3MBTL1 71/4885HSP90AA1 4805/4885NPC1 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.